Regulation of cell proliferation by the guanosine–adenosine mechanism: Role of adenosine receptors

Physiological Reports

Volumn 1, Issue 2, 2013, Pages

  Jackson, Edwin K ^a   Gillespie, Delbert G ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine; Cell proliferation; Guanosine; SLC19 family; SLC22A2

Indexed keywords

1,3 DIPROPYL 8 (4 SULFOPHENYL)XANTHINE; ACICLOVIR; ADENOSINE; ADENOSINE RECEPTOR; CARRIER PROTEINS AND BINDING PROTEINS; CHLOROQUINE; GUANOSINE; METHOTREXATE; REDUCED FOLATE CARRIER; SLC19A2 PROTEIN; SLC19A3 PROTEIN; THIAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL INTERACTION; CELL PROLIFERATION; CORONARY ARTERY; HUMAN; HUMAN CELL; NONHUMAN; RAT; REGULATORY MECHANISM; THYMIDINE INCORPORATION ASSAY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE CELL;

EID: 85008953465     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.1002/phy2.24     Document Type: Article

References (44)

1. Andresen, B. T., D. G. Gillespie, Z. Mi, R. K. Dubey, and E. K. Jackson. 1999. Role of adenosine A1 receptors in modulating extracellular adenosine levels. J. Pharmacol. Exp. Ther. 291: 76–80.
2. Bours, M. J. L., E. L. R. Swennen, F. Di Virgilio, B. N. Cronstein, and P. C. Dagnelie. 2006. Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 112: 358–404.
3. Campbell, J. H., G. Tachas, M. J. Black, G. Cockerill, and G. R. Campbell. 1991. Molecular biology of vascular hypertrophy. Basic Res. Cardiol. 86 (Suppl. 1): 3–11.
4. Chan, E. S. L., and B. N. Cronstein. 2002. Molecular action of methotrexate in inflammatory diseases. Arthritis Res. 4: 266–273.
5. Chan, E. S. L., and B. N. Cronstein. 2010. Adenosine in fibrosis. Mod. Rheumatol. 20: 114–122.
6. Cheng, Y., A. Vapurcuyan, M. Shahidullah, L. M. Aleksunes, and R. M. Pelis. 2012. Expression of organic anion transporter 2 in the human kidney and its potential role in the tubular secretion of guanine-containing antiviral drugs. Drug Metab. Dispos. 40: 617–624.
7. Curcio, A., D. Torella, and C. Indolfi. 2011. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. Circ. J. 75: 1287–1296.
8. Daly, J., and K. Jacobson. 1995. Adenosine receptors: selective agonists and antagonists. Pp. 157–166 in L. Belardinelli and A. Pelleg, eds. Adenosine and adenine nucleotides: from molecular biology to integrative physiology. Kluwer Academic Publishers, Boston, MA.
9. Dubey, R. K., D. Gillespie, Z. Mi, F. Suzuki, and E. K. Jackson. 1996a. Smooth muscle cell-derived adenosine inhibits cell growth. Hypertension 27: 766–773.
10. Dubey, R. K., D. Gillespie, K. Osaka, F. Suzuki, and E. K. Jackson. 1996b. Adenosine inhibits growth of rat aortic smooth muscle cells: possible role of A2b receptor. Hypertension 27: 786–793.
11. Dubey, R. K., E. K. Jackson, H. D. Rupprecht, and R. B. Sterzel. 1997. Factors controlling growth and matrix production in vascular smooth muscle and glomerular mesangial cells. Curr. Opin. Nephrol. Hypertens. 6: 88–105.
12. Dubey, R. K., D. G. Gillespie, Z. Mi, and E. K. Jackson. 1998. Adenosine inhibits growth of human aortic smooth muscle cells via A2B receptors. Hypertension 31: 516–521.
13. Eltzschig, H. K. 2009. Adenosine: an old drug newly discovered. Anesthesiology 111: 904–915.
14. Elwi, A. N., V. L. Damaraju, S. A. Baldwin, J. D. Young, M. B. Sawyer, and C. E. Cass. 2006. Renal nucleoside transporters: physiological and clinical implications. Biochem. Cell Biol. 84: 844–858.
15. Feoktistov, I., I. Biaggioni, and B. N. Cronstein. 2009. Adenosine receptors in wound healing, fibrosis and angiogenesis. Handb. Exp. Pharm. 193: 383–397.
16. Fredholm, B. B. 2010. Adenosine receptors as drug targets. Exp. Cell Res. 316: 1284–1288.
17. Fredholm, B. B., S. Johansson, and Y.-Q. Wang. 2011. Adenosine and the regulation of metabolism and body temperature. Adv. Pharmacol. 61: 77–94.
18. Ganapathy, V., S. B. Smith, and P. D. Prasad. 2004. SLC19: the folate/thiamine transporter family. Pflugers Arch. 447: 641–646.
19. Grenz, A., D. Homann, and H. K. Eltzschig. 2011. Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia. Antioxid. Redox Signal. 15: 2221–2234.
20. Grenz, A., J. D. Bauerle, J. H. Dalton, D. Ridyard, A. Badulak, E. Tak, et al. 2012. Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. J. Clin. Invest. 122: 693–710.
21. Hespel, P., and E. A. Richter. 1998. Role of adenosine in regulation of carbohydrate metabolism in contracting muscle. Adv. Exp. Med. Biol. 441: 97–106.
22. Jackson, E. K., J. Ren, D. G. Gillespie, and R. K. Dubey. 2010. Extracellular 2′, 3′-cyclic adenosine 5′-monophosphate is a potent inhibitor of preglomerular vascular smooth muscle cell and mesangial cell growth. Hypertension 56: 151–158.
23. Jackson, E. K., D. G. Gillespie, and R. K. Dubey. 2011a. 2′-AMP and 3′-AMP inhibit proliferation of preglomerular vascular smooth muscle cells and glomerular mesangial cells via A2B receptors. J. Pharmacol. Exp. Ther. 337: 444–450.
24. Jackson, E. K., J. Ren, and D. G. Gillespie. 2011b. 2′, 3′-cAMP, 3′-AMP and 2′-AMP inhibit human aortic and coronary vascular smooth muscle cell proliferation via A2B receptors. Am. J. Physiol. Heart Circ. Physiol. 301: H391–H401.
25. Jackson, E. K., D. Cheng, T. C. Jackson, J. D. Verrier, and D. G. Gillespie. 2013. Extracellular guanosine regulates extracellular adenosine levels. Am. J. Physiol. Cell Physiol. 304: C406–C421.
26. Jacobson, K. A. 2009. Introduction to adenosine receptors as therapeutic targets. Handb. Exp. Pharm. 193: 1–24.
27. Kumar, V., and A. Sharma. 2009. Adenosine: an endogenous modulator of innate immune system with therapeutic potential. Eur. J. Pharmacol. 616: 7–15.
28. Marshall, J. M. 2002. Roles of adenosine in skeletal muscle during systemic hypoxia. Clin. Exp. Pharmacol. Physiol. 29: 843–849.
29. Mohsenin, A., and M. R. Blackburn. 2006. Adenosine signaling in asthma and chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med. 12: 54–59.
30. Mokkapatti, R., S. J. Vyas, G. G. Romero, Z. Mi, T. Inoue, R. K. Dubey, et al. 1998. Modulation by angiotensin II of isoproterenol-induced cAMP production in preglomerular microvascular smooth muscle cells from normotensive and genetically hypertensive rats. J. Pharmacol. Exp. Ther. 287: 223–231.
31. Mustafa, S. J., R. R. Morrison, B. Teng, and A. Pelleg. 2009. Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology. Handb. Exp. Pharm. 193: 161–188.
32. Pelleg, A., G. Katchanov, and J. Xu. 1997. Autonomic neural control of cardiac function: modulation by adenosine and adenosine 5′-triphosphate. Am. J. Cardiol. 79: 11–14.
33. Peng, Z., P. Fernandez, T. Wilder, H. Yee, L. Chiriboga, E. S. L. Chan, et al. 2008. Ecto-5′-nucleotidase (CD73)-mediated extracellular adenosine production plays a critical role in hepatic fibrosis. Nucleosides Nucleotides Nucleic Acids 27: 821–824.
34. Sebastiao, A. M., and J. A. Ribeiro. 2009. Adenosine receptors and the central nervous system. Handb. Exp. Pharm. 193: 471–534.
35. Thauerer, B., S. zur Nedden, and G. Baier-Bitterlich. 2012. Purine nucleosides: endogenous neuroprotectants in hypoxic brain. J. Neurochem. 121: 329–342.
36. Tian, H., and B. N. Cronstein. 2007. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis. Bull. NYU Hosp. Jt. Dis. 65: 168–173.
37. Traversa, U., G. Bombi, E. Camaioni, A. Macchiarulo, G. Costantino, C. Palmieri, et al. 2003. Rat brain guanosine binding site. Biological studies and pseudo-receptor construction. Bioorg. Med. Chem. 11: 5417–5425.
38. Trincavelli, M. L., S. Daniele, and C. Martini. 2010. Adenosine receptors: what we know and what we are learning. Curr. Top. Med. Chem. 10: 860–877.
39. Vallon, V., B. Muhlbauer, and H. Osswald. 2006. Adenosine and kidney function. Physiol. Rev. 86: 901–940.
40. Valls, M. D., B. N. Cronstein, and M. C. Montesinos. 2009. Adenosine receptor agonists for promotion of dermal wound healing. Biochem. Pharmacol. 77: 1117–1124.
41. Vass, G., and I. Horvath. 2008. Adenosine and adenosine receptors in the pathomechanism and treatment of respiratory diseases. Curr. Med. Chem. 15: 917–922.
42. Westfall, D. P., K. Shinozuka, K. M. Forsyth, and R. A. Bjur. 1990. Presynaptic purine receptors. Ann. NY Acad. Sci. 604: 130–135.
43. Yu, W., L. C. Zacharia, E. K. Jackson, and G. Apodaca. 2006. Adenosine receptor expression and function in bladder uroepithelium. Am. J. Physiol. Cell Physiol. 291: C254–C265.
44. Yu, W., S. C. Robson, and W. G. Hill. 2011. Expression and distribution of ectonucleotidases in mouse urinary bladder. PLoS ONE 6: e18704.